Lupin Ltd is in the Pharmaceuticals sector with the Market Capitalization of worth Rs. 44,266.89 crores, it is incorporated in the year 1968. It has a reported consolidated sales of Rs. 4,237.39 crores in June’2021. The company is also listed in the Bombay Stock Exchange (BSE) with the code 500257 and also listed in the National Stock Exchange (NSE) with the code LUPIN.
Lupin Ltd is an Indian international pharmaceuticals company and is one of the largest generic pharmaceuticals companies globally based on revenue. The company primarily focuses on six areas, namely, paediatrics, cardiovascular, anti-infectives, diabetology, asthma, and anti- tuberculosis. Lupin has a global presence with operations spreading across 11 nations and 6 continents. Lupin has a team of over 1400 scientists working at Research 7 development headquarters located near Pune. Lupin ltd meets its corporate social responsibility through The Lupin Human Welfare & Research Foundation set up in 1988. The foundation mainly focuses on rural development projects that have reached over 3400 villages across eight states in the country to date. The promoters of the company own 46.84% of the stake in the company, Foreign Institutional Investors (FII) own 18.6%, Domestic Institutional Investors (DII) own 22.09% of the stake, and others (such as retail investors) hold the balance of 12.47%.
In June 2021, quarterly net revenue was Rs. 3,314.12 crores, which has increased by approximately 22.97 % from Rs. 2,695.08 crores for the April-June 2020 quarter. The quarterly net profit in June 2021 was Rs. 645.87 crores, which has seen an increase by nearly 77.64 % from a net profit of Rs. 363.58 crores in June 2020. In June 2021, the reported operating profit was at Rs. 2,617.15 crores, which is also increased by 26.76% as compared to an operating profit of Rs. 2,064.73 crores for the quarter ending in June 2020. From Rs. 8.03 in June 2020, the EPS of Lupin Ltd has almost doubled and reached Rs. 14.13 per share in June 2021. LUPIN’s stock closed at Rs. 974.10 on 17th August’2021 (NSE) and has returned -8.29% in the last six months and -2.83% in the previous year.
Lupin share price as on 16 Aug 2024 is Rs. 2086.05. Over the past 6 months, the Lupin share price has increased by 29.43% and in the last one year, it has increased by 92.8%. The 52-week low for Lupin share price was Rs. 1064.1 and 52-week high was Rs. 2131.55.